Navigated laser in diabetic macular edema: the impact of reduced injection burden on patients and physicians-who wins and who loses?
We inquired the impact of reduced therapy discontinuation in diabetic macular edema (DME) on physician’s revenue considering anti-vascular endothelial growth factor (VEGF) monotherapy and its combination with Navilas treatment. Data were collected on injection frequency, treatment discontinuation an...
Main Authors: | Jacob Menzler, Aljoscha Neubauer, Focke Ziemssen |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2019-02-01
|
Series: | International Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.cn/en_publish/2019/2/20190224.pdf |
Similar Items
-
Topical interferon therapy in uveitic macular edema
by: Ankush Kawali, et al.
Published: (2022-01-01) -
Some considerations about the diabetic macular edema
by: Blanca Nieve Rey Estevez, et al.
Published: (2017-05-01) -
Cystoid macular edema secondary to ibrutinib
by: Ravid Ben-Avi, et al.
Published: (2022-06-01) -
Algunas consideraciones sobre el edema macular diabético
by: Blanca Nieve Rey Estevez, et al. -
Real-world treatment patterns and economic burden of post-cataract macular edema
by: Gina Ahmadyar, et al.
Published: (2023-09-01)